HMOX1 and Sepsis: By activating the SIRT1/Sestrin2/HO-1 axis, Tanshinone IIA counteracts LPS-induced inflammatory responses, demonstrating promising therapeutic potential in ameliorating sepsis-related hepatic dysfunction [63].